Abstract

Background: The topological analysis of networks extracted from different types of "omics" data is a useful strategy for characterizing biologically meaningful properties of the complex systems underlying these networks. In particular, the biological significance of highly connected genes in diverse molecular networks has been previously determined using data from several model organisms and phenotypes. Despite such insights, the predictive potential of candidate hubs in gene co-expression networks in the specific context of cancer-related drug experiments remains to be deeply investigated. The examination of such associations may offer opportunities for the accurate prediction of anticancer drug responses. Methods: Here, we address this problem by: a) analyzing a co-expression network obtained from thousands of cancer cell lines, b) detecting significant network hubs, and c) assessing their capacity to predict drug sensitivity using data from thousands of drug experiments. We investigated the prediction capability of those genes using a multiple linear regression model, independent datasets, comparisons with other models and our own in vitro experiments. Results: These analyses led to the identification of 47 hub genes, which are implicated in a diverse range of cancer-relevant processes and pathways. Overall, encouraging agreements between predicted and observed drug sensitivities were observed in public datasets, as well as in our in vitro validations for four glioblastoma cell lines and four drugs. To facilitate further research, we share our hub-based drug sensitivity prediction model as an online tool. Conclusions: Our research shows that co-expression network hubs are biologically interesting and exhibit potential for predicting drug responses in vitro. These findings motivate further investigations about the relevance and application of our unbiased discovery approach in pre-clinical, translationally-oriented research.

Highlights

  • The analysis of networks extracted from different types of “omics” data is a useful strategy to enable the characterization and prediction of meaningful properties of the underlying complex biological systems[1,2,3]

  • Our findings further suggest that our network hubs are relevant for predicting drug sensitivity, and highlight challenges in a drug-specific context

  • We investigated the relationship between hubs detected in a pan-cancer co-expression network and drug sensitivity in vitro

Read more

Summary

Introduction

The analysis of networks extracted from different types of “omics” data is a useful strategy to enable the characterization and prediction of meaningful properties of the underlying complex biological systems[1,2,3]. The predictive potential of candidate hubs in gene co-expression networks in the specific context of cancer-related drug experiments remains to be thoroughly investigated An examination of such associations may offer novel opportunities for the accurate prediction and understanding of anticancer drug responses. The biological significance of highly connected genes in diverse molecular networks has been previously determined using data from several model organisms and phenotypes Despite such insights, the predictive potential of candidate hubs in gene co-expression networks in the specific context of cancer-related drug experiments remains to be deeply investigated. The predictive potential of candidate hubs in gene co-expression networks in the specific context of cancer-related drug experiments remains to be deeply investigated The examination of such associations may offer opportunities for the accurate prediction of anticancer drug responses. These findings motivate further investigations about the relevance and application of our unbiased discovery approach in pre-clinical, translationally-oriented research

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.